Treatment of iron deficiency in patients scheduled for pancreatic surgery: implications for daily prehabilitation practice in pancreatic surgery

Table 3 Surgical details and postoperative outcomes

	IVIS-group n = 25 (15.2%)	SC-group n = 139 (84.8%)	p-value
Surgical procedure			0.79
Pancreatoduodenectomy	20 (80)	107 (77)
Distal pancreatectomy	3 (12)	23 (16.5)
Other	2 (8)	9 (6.5)
Complementary resection	5 (20)	27 (19.4)	0.95
Vascular resection
Arterial	0	6 (4.3)	0.59
Venous	4 (16)	28 (20.1)	0.79
Intraoperative blood loss: ml	500 (400–800)	400 (250–737.5)	0.07
Length of hospital stay: days	12 (9–20)	11 (8–17)	0.23
Surgery specific complications
POPF ≥ grade B	4 (16)	27 (19.4)	0.79
DGE ≥grade B	6 (24)	30 (21.6)	0.79
BL ≥ grade B	1 (4)	3 (2.2)	0.49
PPH ≥ grade B	2 (8)	9 (6.5)	0.68
CL ≥ grade B	4 (16)	12 (8.6)	0.27
SSI	1 (4)	36 (25.9)	0.02
RBC transfusion	9 (36)	29 (20.9)	0.10
In-hospital mortality	1 (4)	3 (2.2)	0.49
Unplanned readmission < 30 days	4 (16)	18 (12.9)	0.75

Data are presented as median (IQR) or number (%)
Abbreviations: IVIS Intravenous iron supplementation, SC Standard care, POPF Postoperative pancreatic fistula, DGE Delayed gastric emptying, BL Bile leakage, PPH Post-pancreatectomy hemorrhage, CL Chyle leakage, SSI Surgical site infections, RBC Red blood cell, ICU Intensive care unit

ISSN: 2047-0525